Episode
Peptides Won’t Save You: The Hard Truth About Age-less Medicine
- Published
- Feb 15, 2026
- Duration seconds
- 2238
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/the-science-of-age-less-living/2550048
Actions
POST https://stenobird.com/v1/public/podcasts/the-science-of-age-less-living-7235688/episodes/peptides-won-t-save-you-the-hard-truth-about-age-less-medicine/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-science-of-age-less-living-7235688/peptides-won-t-save-you-the-hard-truth-about-age-less-medicine.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of The Science of Age-less Living , Dr. Ethan cuts through the noise around “anti-aging” and peptide culture to lay out what longevity medicine actually is: evidence-based risk management, not influencer-driven optimization. You’ll hear why the biggest threats to lifespan and healthspan are still cardiovascular disease, metabolic dysfunction, neurodegeneration, and cancer—and why no peptide stack can compensate for ignored biomarkers, unchecked ApoB, poor glucose control, or low fitness. Dr. Ethan breaks longevity into a practical hierarchy: Tier 1 fundamentals (sleep, VO2 max, ApoB control, insulin sensitivity), Tier 2 amplifiers (mitochondrial function, inflammation control, physiologic hormone optimization), and only then Tier 3—targeted peptides used selectively, with clear indications and lab monitoring. He highlights where specific peptides may have legitimate utility in narrow clinical contexts, and calls out the most common “longevity clinic” hype—from exosomes and stem-cell claims to reckless GLP-1 use in already-lean patients. The takeaway is simple: peptides can be useful tools, but they’re not the foundation. Real longevity comes from mastering the boring, proven levers—and using advanced interventions only when the data says you actually need them.